Standardized outcome measurement for patients with coronary artery disease: consensus from the International Consortium for Health Outcomes Measurement (ICHOM)
Files
(Published version)
Date
2015
Authors
McNamara, R.L.
Spatz, E.S.
Kelley, T.A.
Stowell, C.J.
Beltrame, J.
Heidenreich, P.
Tresserras, R.
Jernberg, T.
Chua, T.
Morgan, L.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of the American Heart Association, 2015; 4(5):e001767-1-e001767-9
Statement of Responsibility
Robert L. McNamara, Erica S. Spatz, Thomas A. Kelley, Caleb J. Stowell, John Beltrame, Paul Heidenreich, Ricard Tresserras, Tomas Jernberg, Terrance Chua, Louise Morgan, Bishnu Panigrahi, Alba Rosas Ruiz, John S. Rumsfeld, Lawrence Sadwin, Mark Schoeberl, David Shahian, Clive Weston, Robert Yeh, Jack Lewin
Conference Name
Abstract
BACKGROUND Coronary artery disease (CAD) outcomes consistently improve when they are routinely measured and provided back to physicians and hospitals. However, few centers around the world systematically track outcomes, and no global standards exist. Furthermore, patient‐centered outcomes and longitudinal outcomes are under‐represented in current assessments. METHODS AND RESULTS The nonprofit International Consortium for Health Outcomes Measurement (ICHOM) convened an international Working Group to define a consensus standard set of outcome measures and risk factors for tracking, comparing, and improving the outcomes of CAD care. Members were drawn from 4 continents and 6 countries. Using a modified Delphi method, the ICHOM Working Group defined who should be tracked, what should be measured, and when such measurements should be performed. The ICHOM CAD consensus measures were designed to be relevant for all patients diagnosed with CAD, including those with acute myocardial infarction, angina, and asymptomatic CAD. Thirteen specific outcomes were chosen, including acute complications occurring within 30 days of acute myocardial infarction, coronary artery bypass grafting surgery, or percutaneous coronary intervention; and longitudinal outcomes for up to 5 years for patient‐reported health status (Seattle Angina Questionnaire [SAQ‐7], elements of Rose Dyspnea Score, and Patient Health Questionnaire [PHQ‐2]), cardiovascular hospital admissions, cardiovascular procedures, renal failure, and mortality. Baseline demographic, cardiovascular disease, and comorbidity information is included to improve the interpretability of comparisons. CONCLUSIONS ICHOM recommends that this set of outcomes and other patient information be measured for all patients with CAD.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.